TSRGet The Daily Report
The Singularity Report

TSR Desk · science · 25 September 2026, 01:00 UTC

Glucose-ML: A collection of longitudinal diabetes datasets for development of robust AI

What
Glucose-ML: A collection of longitudinal diabetes datasets for development of robust AI solutions
Who
arxiv.org
When
24 September 2026, 04:00 UTC
Category
Science
Primary source
https://arxiv.org/abs/2507.14077
What is not known
This brief does not claim independent replication. Claims that appear only on X and not in the primary source stay unknown.

Artificial intelligence (AI) algorithms are a critical part of state-of-the-art digital health technology for diabetes management. It comes from a paper posted to arXiv on 24 September 2026. Yet, access to large high-quality datasets is creating barriers that impede development of robust AI solutions. To accelerate development of transparent, reproducible, and robust AI solutions, we present Glucose-ML, a collection of 10 publicly available diabetes datasets, released within the last 7 years (i.e., 2018 - 2025). The Glucose-ML collection comprises over 300,000 days of continuous glucose monitor (CGM) data with a total of 38 million glucose samples collected from 2500+ people across 4 countries. Participants include persons living with type 1 diabetes, type 2 diabetes, prediabetes, and no diabetes. To support researchers and innovators with using this rich collection of diabetes datasets, we present a comparative analysis to guide algorithm developers with data selection. Additionally, we conduct a case study for the task of blood glucose prediction - one of the most common AI tasks within the field. Through this case study, we provide a benchmark for short-term blood glucose prediction across all 10 publicly available diabetes datasets within the Glucose-ML collection. We show that the same algorithm can have significantly different prediction results when developed/evaluated with different datasets. Findings from this study are then used to inform recommendations for developing robust AI solutions within the diabetes or broader health domain. We provide direct links to each longitudinal diabetes dataset and openly provide our code.

Why it counts

Artificial intelligence (AI) algorithms are a critical part of state-of-the-art digital health technology for diabetes management.

Sources

Primary source: primary source

What is not known

This brief does not claim independent replication. Claims that appear only on X and not in the primary source stay unknown.

No clip. The article still stands.